PROSTAID CalgaryCalgary's Prostate Cancer Support Group  
Monthly Meeting: Tuesday, November 14th at the Kerby Centre downtown. Cathy Ormon talks Sugar and its impact on pH balance and cancer.

Pathfinder's Award

Increase font size Decrease font size Reset font size

Established in 2014, the Pathfinder's Award recognizes individuals who have contributed significant service to helping men and their families deal with prostate cancer.

Join us on Tuesday, December 10 as we celebrate Dr. Dean Ruether and his many achievements and contributions to the prostate cancer community.

Dr. Ruether is a Medical Oncologist at the TBCC who has worked in the GU program for over 20 years. His undergraduate training was done at the University of Calgary and medical school completed at the University of Alberta.  Post graduate training in internal medicine, hematology and medical oncology was completed at the University of Calgary with focus on Clinical Trials in GU, Endocrine and Neuroendcrine malignancies and Patient Education. He is an active member of the Medical Oncology training program, serves on a number of administrative capacities, as the Lead for local tumour group teams and is responsible for bringing clinical trials for the Endocrine and NET and Prostate patient population in Alberta.  Dr. Ruether is also the current Medical Director, Community Oncology, CancerCare Alberta for 4 regional and 11 community sites whose directive is to bring cancer care closer to home for Albertans.

In previous leadership roles for the local and provincial GU and Endocrine & Neuroendocrine programs in Alberta, Dr Ruether played a pivotal role in bringing clinical trials for patients affected by GU and Endocrine malignancies to Alberta.  Results of some of these trials have changed practice in both of these subspecialty areas of oncology. Dr Ruether has also been involved in a series of clinical trials looking at the benefits of providing consultation recordings to patients affected by GU, Breast, CNS and Neuroendocrine tumors.  Results of these trials have been instrumental in establishing a consultation recording service in Cancer Care Manitoba and work to establish a similar service as part of standard operations is underway here in Alberta. As the Medical Director for Community Oncology, Dr. Ruether has been successful in obtaining funding from the ACF to support the development of the necessary clinical infrastructure needed to provide access to clinical trials in 3 of our 4 regional cancer centers. Dr. Ruether has been involved as the local principal investigator in multiple phase 2 and 3 trials in the GU, Endocrine, Breast, and malignant hematology as well as a phase 1 trial in bladder cancer over a career spanning 22 years and is coauthor on more than 50 peer reviewed publications that have come out of participation in clinical research trials.

PROSTAID Calgary Pathfinder’s Award Celebration
Date: Tuesday, December 10, 2017
Location: Kerby Centre, 1133 7th Ave SW. 
Lecture Room, Room 205

Agenda
6:30pm - 7:30pm Meet & Greet 
7:30pm - 7:45pm Opening/Welcoming remarks by Dave Lunn
7:45pm - 8:15pm Award Ceremony
8:15pm - 8:20pm Closing remarks by Dave Lunn
8:20pm - 9pm Wine and appetisers

The Pathfinder’s Award Celebration is open to the public and there is no cost to attend.

[+] 2016

[+] 2015

Donate Now to PROSTAID Calgary

Quick Links

• The Digital Examiner Journal
• Online Meeting Video Archive
• Who is PROSTAID Calgary?
• Contact Us

 
PROSTAID Calgary on Twitter PROSTAID Calgary on Facebook PROSTAID Calgary on YouTube Email PCCN Calgary Become a PROSTAID Calgary Member Today!
hits since 02.27.2008

Maybe you can live without a PSA test...but why take the chance?
PROSTAID Calgary is your first destination for prostate cancer support in Calgary, Alberta, Canada and across the world with information and support through our online videos, support meetings, prostate cancer news, and awareness initiatives.


All Rights Reserved . © 2005-2017 . PROSTAID Calgary & PCCN Calgary . Charitable Registration Number: BN 86926 1602 RR0001
Site Designed & Maintained by Rhettoric Media.